Abstract
Throughout the COVID-19 Pandemic, the symptoms of loss of smell and taste have been commonly encountered by healthcare professionals, and in fact, have become an important screening tool. By some estimates, 96% of COVID-19 patients experience these symptoms to various degrees [1]. While the exact mechanism of cellular events that lead to loss of smell and taste is largely unknown, research is underway to better understand the process. The senses are usually regained with time but often can take months, and in some instances, be permanent [2]. Nearly one out of ten patients have not fully recovered by two months and treatment options so far are limited [3]. The use of a low dose of Gabapentin could be a possible treatment for anosmia and ageusia in COVID-19 patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
